Quality Assurance Assessment of Diffusion-Weighted and T2-Weighted Magnetic Resonance Imaging Registration and Contour Propagation for Head and Neck Cancer Radiotherapy

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported by the National Institutes of Health (NIH) through a Cancer Center Support Grant (P30-CA016672-44). K.A. Wahid and T.C. Salzillo are supported by training fellowships from The University of Texas Health Science Center at Houston Center for Clinical and Translational Sciences TL1 Program (TL1TR003169). K.A. Wahid is also supported by the American Legion Auxiliary Fellowship in Cancer Research and a NIDCR F31 fellowship (1 F31 DE031502-01). B.A. McDonald receives research support from an NIH NIDCR Award (F31DE029093) and the Dr. John J. Kopchick Fellowship through The University of Texas MD Anderson UTHealth Graduate School of Biomedical Sciences. C.D. Fuller received funding from an NIH NIDCR Award (1R01 DE025248-01/R56 DE025248) and Academic-Industrial Partnership Award (R01 DE028290); the National Science Foundation (NSF), Division of Mathematical Sciences, Joint NIH/NSF Initiative on Quantitative Approaches to Biomedical Big Data (QuBBD) Grant (NSF 1557679); the NIH Big Data to Knowledge (BD2K) Program of the National Cancer Institute (NCI) Early Stage Development of Technologies in Biomedical Computing, Informatics, and Big Data Science Award (1R01 CA214825); the NCI Early Phase Clinical Trials in Imaging and Image-Guided Interventions Program (1R01 CA218148); the NIH/NCI Cancer Center Support Grant (CCSG) Pilot Research Program Award from the UT MD Anderson CCSG Radiation Oncology and Cancer Imaging Program (P30 CA016672); the NIH/NCI Head and Neck Specialized Programs of Research Excellence (SPORE) Developmental Research Program Award (P50 CA097007); and the National Institute of Biomedical Imaging and Bioengineering (NIBIB) Research Education Program (R25 EB025787). He has received direct industry grant support, speaking honoraria, and travel funding from Elekta AB.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

All clinical and imaging data were generated between May 30, 2017 and April 1, 2019 and were retrospectively collected under a HIPAA-compliant protocol (PA16-0302) that was approved by The University of Texas MD Anderson Cancer Centers institutional review board. All patients provided study-specific informed consent.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes